Specifically, these results suggested that the naïve T cell subpopulation in NSCLC patients differentiates toward the effector memory T cell subpopulation after antigen stimulation, and high expression of PD-1 on CD4+ T cells may be responsible for the suppression of antitumor effects [22]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.